Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Mellitus × dapagliflozin × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 10 Polycystic Ovary Syndrome 4 Prostatic Neoplasms 2 Solid Tumors 1 Pediatric Brain Tumor 1 Pancreatic Neoplasms 1 Obesity 1 Lung Neoplasms 1 Inflammation 1 Hyperinsulinism 1 Hyperglycemia 1 Hereditary Sensory and Autonomic Neuropathies 1 Heart Failure 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1 Cardiotoxicity 1 Adenocarcinoma of Lung 1

Interventions

Metformin 7 Educational Status 3 Tirzepatide 2 Tablets 2 Surveys and Questionnaires 2 Standard of Care 2 Specimen Handling 2 Pioglitazone 2 Nutrition Assessment 2 Methods 2 Interviews as Topic 2 Glucose Tolerance Test 2 Exercise 2 tocilizumab 1 sofosbuvir-velpatasvir drug combination 1 saxagliptin 1 pembrolizumab 1 otelixizumab 1 nabiximols 1 esmolol 1 dapagliflozin 1 amlodipine, atorvastatin drug combination 1 Verapamil 1 Urine Specimen Collection 1 Therapeutics 1 Testosterone 1 Secretin 1 Second Harmonic Generation Microscopy 1 Risk Assessment 1 Preventive Health Services 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡